About David O'Neill
Form D filings for CTRL Therapeutics USA from 2022 to 2024 list David O'Neill as director.
David O'Neill first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name David O'Neill in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people David O'Neill works with at each company, as listed on that company's latest Form D.
CTRL Therapeutics USA, Inc. · Form D, Sep 27, 2024
DP
Derrell Porter
Chief Executive Officer and director
CT
Collin Todd
Director
SK
Shana Kelley
Executive officer and director